Agrifood giant Archer Daniels Midland recently stepped further into health ingredients when it signed an agreement with US company Nutraceutix for ADM to use Nutraceutix' patented Controlled Delivery Technology (CDT) to develop and market dietary supplements.
ADM will market its products using the technology on an exclusive global basis to dietary supplement manufacturers.
The first product to be marketed is soy isoflavone supplement, Novasoy Daily Dose.
"Nutraceutix' CDT technology allows us to tailor the biological delivery of dietary supplements to maximise its health benefits and, in most cases, better simulate the natural function of the human body. We expect to see applications in an entire range of dietary supplements," said Tony DeLio, ADM vice president, marketing and external affairs. "This represents a significant advancement in supplement technology and demonstrates ADM's continued commitment to bringing innovation and science to supplements and functional foods," he continued.
David T. Howard, CEO of Nutraceutix confirmed ADMs words: "The Nutraceutix and ADM alliance marries ADM's expertise in the natural nutraceutical market with Nutraceutix' patented CDT to develop better performing dietary supplements. ADM's global reach allows us to make these products available worldwide."
Products from the ADM Natural Health and Nutrition stable include Novasoy isoflavones, vitamin E, CardioAid, NutriSoy soy protein and Soy7.